Why do some cancer patients experience extraordinary recoveries with immunotherapy, while others show little improvement? Until recently, answers to this question focused on tumor genetics or immune checkpoint mechanisms. However, an unexpected player has begun to take center stage in this equation: the gut.
During the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO), researchers presented compelling evidence, reported by Healio, pointing to a new factor that can significantly enhance the effectiveness of immunotherapy in patients with melanoma: a high-fiber diet. This finding not only opens new perspectives for cancer treatment, but also redefines the conversation about how diet, immunity, and medical therapies are interconnected.
The gut microbiome, made up of trillions of microorganisms that inhabit our digestive tract, plays an essential role in regulating the immune system. Although it was long overlooked, today we know that its influence extends far beyond the intestine. In this study, more than 400 patients treated with immune checkpoint inhibitors were evaluated. Those who consumed more than 20 grams of fiber per day showed a higher clinical response rate and significantly longer progression-free survival.
The secret seems to lie in the interaction between diet, gut microbes, and immune cells. Dietary fiber—found primarily in fruits, vegetables, legumes, and whole grains—is not digested in the upper gastrointestinal tract. Instead, it reaches the colon, where it is fermented by beneficial bacteria. This process produces short-chain fatty acids (SCFAs), such as butyrate, which not only nourish intestinal cells but also modulate the immune system’s activity systemically.
These metabolites act as epigenetic signals, helping activate, expand, and sustain cytotoxic T lymphocytes, which are responsible for attacking and eliminating tumor cells. A healthy and diverse intestinal environment, supported by fiber, favors a more “inflamed” tumor microenvironment—which, paradoxically, is a good sign: it means the immune system is active inside the tumor and better able to respond to immunotherapy.
An additional finding from the study is that probiotic supplements do not offer the same benefits. In fact, in some cases, they may interfere with the natural balance of the microbiome. Unlike these supplements, a rich and varied fiber intake promotes microbial diversity sustainably, without disrupting the intestinal ecosystem.
This discovery reinforces an emerging idea in precision medicine: that personalized nutrition should be an integral part of therapeutic strategies against cancer. It’s not just about avoiding processed foods or eating more fruit—it’s about using diet as an active tool to strengthen the body’s defenses.
Figure 1. Dietary fiber boosts gut microbiota and SCFA production, promoting T cell function and supporting a more inflamed, responsive tumor microenvironment during immune checkpoint blockade.
Although this study focused on melanoma, its implications may extend to other cancers also treated with immunotherapy, such as lung, colon, or breast cancer. The gut–immunity–tumor axis seems to be a universal field that could revolutionize cancer treatments in the coming years.
Ultimately, this work invites us to reconsider food as more than just a lifestyle choice. Perhaps the path to more effective therapies doesn’t begin in the lab, but at the market—or in the kitchen. Because in this new era of precision medicine, food doesn’t just nourish: it can also heal, modulate, and empower. And in the fight against cancer, that silent advantage might be right on your plate.
Main Reference:
Source: Qiu Y, et al. Abstract 9511. Presented at: ASCO Annual Meeting; May 30-June 3, 2024; Chicago. https://www.healio.com/news/hematology-oncology/20250603/highfiber-diet-could-improve-response-to-immunotherapy-for-patients-with-melanoma
